<div class="headers"><div>CENTRAL ILLUSTRATION Dual Antiplatelet Therapy With Complex Lesions: Cumulative Incidence of Endpoint Events From 12 to 30 Months After RandomizationThe endpoint events were stratiﬁed by randomized treatment arm and number of anatomical complexity characteristics. Outcomes were analyzed comparing randomized treatments among subgroups of subjects with 0 (n ¼ 7,824), 1 (n ¼ 3,182), or 2 or more (n ¼ 548) anatomic complexity characteristics to assess whether treatment effects differed depending on the number of complexity factors</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'><p class="">CENTRAL ILLUSTRATION Dual Antiplatelet Therapy With Complex Lesions: Cumulative Incidence of Endpoint Events From 12 to 30 Months After Randomization</p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">The endpoint events were stratiﬁed by randomized treatment arm and number of anatomical complexity characteristics. Outcomes were analyzed comparing randomized treatments among subgroups of subjects with 0 (n ¼ 7,824), 1 (n ¼ 3,182), or 2 or more (n ¼ 548) anatomic complexity characteristics to assess whether treatment effects differed depending on the number of complexity factors</p></td>
</tr>
</tbody>
</table>
